28 Recruiting Urothelial Cancer Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by Study Phase
Top Interventions for Urothelial Cancer
Related Conditions
Top Recruiting Urothelial Cancer Studies
Enfortumab Vedotin and Pembrolizumab vs. Chemotherapy Alone in Untreated Locally Advanced or Metastatic Urothelial Cancer
📍 Ironwood Cancer & Research Centers - Chandler — Chandler, Arizona
View Study & Checklist ➔A Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast Growth Factor Receptor (FGFR) Gene Aberrations
📍 Alaska Urological Institute dba Alaska Clinical Research Center — Anchorage, Alaska
View Study & Checklist ➔A Study Evaluating Different Immunotherapies (LAG-3 and PD-1 With or Without TIGIT, Compared to PD-L1 Alone) in Participants With Untreated Locally Advanced Metastatic Urothelial Cancer
📍 Cleveland Clinic — Cleveland, Ohio
View Study & Checklist ➔A Genotype-Phenotype Urothelial Cancer Registry
📍 Memorial Sloan Kettering Basking Ridge — Basking Ridge, New Jersey
View Study & Checklist ➔Bintrafusp Alfa (M7824) and PDS01ADC Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary Malignancies
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔Study of MEDI4736 (Durvalumab) With or Without Tremelimumab Versus Standard of Care Chemotherapy in Urothelial Cancer
📍 Research Site — Los Angeles, California
View Study & Checklist ➔An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial Cancer
📍 Clinical Research Facility — Sedona, Arizona
View Study & Checklist ➔Study of Nivolumab in Combination With Ipilimumab or Standard of Care Chemotherapy Compared to the Standard of Care Chemotherapy Alone in Treatment of Participants With Untreated Inoperable or Metastatic Urothelial Cancer
📍 Local Institution - 0001 — Anchorage, Alaska
View Study & Checklist ➔Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
📍 Research Site — Fullerton, California
View Study & Checklist ➔Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer
📍 Lahey Clinic, Inc. — Burlington, Massachusetts
View Study & Checklist ➔Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
📍 Highlands Oncology Group, PA — Fayetteville, Arkansas
View Study & Checklist ➔Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
📍 Samsun Clinic - Ridley-Tree Cancer Center — Santa Barbara, California
View Study & Checklist ➔Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
📍 Local Institution - 0167 — Gilbert, Arizona
View Study & Checklist ➔A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔Sacituzumab Govitecan Plus EV in Metastatic UC
📍 Dana Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔